Novartis AG ADR sell Barclays PLC
Start price
22.02.25
/
50%
€103.50
Target price
22.02.26
-
Performance (%)
32.85%
End price
23.02.26
€137.50
Summary
This prediction ended on 23.02.26 with a price of €137.50. The SELL prediction by Barclays_PLC for Novartis AG ADR was trending in the completely wrong direction and closed with a performance of 32.85%. Dividends of €3.87 are taken into consideration when calculating the performance. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novartis AG ADR | -3.597% | -3.597% | 31.373% |
| iShares Core DAX® | 3.153% | 1.504% | 9.129% |
| iShares Nasdaq 100 | 7.431% | -1.584% | 28.642% |
| iShares Nikkei 225® | 8.571% | -4.324% | 53.026% |
| iShares S&P 500 | 4.578% | 1.920% | 23.965% |
Comments by Barclays_PLC for this prediction
In the thread Novartis AG ADR diskutieren
Novartis AG (NYSE: NVS) had its "underweight" rating re-affirmed by analysts at Barclays PLC.
Ratings data for NVS provided by MarketBeat
In the thread Trading Novartis AG ADR
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten